Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure - PubMed (original) (raw)
. 2007 Nov;53(11):1886-90.
doi: 10.1373/clinchem.2007.088302. Epub 2007 Sep 21.
Affiliations
- PMID: 17890443
- DOI: 10.1373/clinchem.2007.088302
Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure
Cristina Vassalle et al. Clin Chem. 2007 Nov.
Abstract
Background: Genetic variants related to the natriuretic peptide (NP) system [ScaI mutated allele (A1) of the atrial NP (ANP) gene and the C variant of the natriuretic peptide clearance receptor (NPRC) gene] have been identified as independent risk factors for cardiovascular morbidity and mortality. Despite the importance of NPs in heart failure (HF), the role of these polymorphisms in HF has not been evaluated.
Methods: We screened 124 HF patients [mean (SD), age 66 (12) years, 100 men, ejection fraction 32% (10%), New York Heart Association (NYHA) class I-II 65, III-IV 59] for NP concentrations [ANP, brain NP (BNP) and amino-terminal pro-BNP (NT-proBNP)] and for the ScaI and NPRC variants.
Results: ScaI polymorphism had no effect on NP concentration in the NYHA I-II subgroup. Conversely, in severe HF, A1 carriers had higher ANP (P < or =0.05), BNP (P <0.01), and NT-proBNP (P <0.01) than A2A2 patients. After multivariate adjustment, A1 presence remained an independent predictor for increased NP. Regarding NPRC polymorphism in mild HF, higher ANP (P <0.05) and BNP (P <0.05) were observed in CC than A allele carriers. After multivariate adjustment, however, this association did not remain significant. In severe HF, the NPRC polymorphism had no effect on NP.
Conclusions: The ScaI polymorphism of the ANP gene might be an important additive genetic factor influencing neurohormonal activation and disease progression in severe HF. The NPRC polymorphism is not an independent determinant of NP concentration in HF.
Similar articles
- Genetic variation in the natriuretic peptide system and heart failure.
Lanfear DE. Lanfear DE. Heart Fail Rev. 2010 May;15(3):219-28. doi: 10.1007/s10741-008-9113-y. Epub 2008 Oct 11. Heart Fail Rev. 2010. PMID: 18850266 Free PMC article. Review. - Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R, Wang D, Sullivan R, Fan TH, Gladysheva IP, Reed GL. Tripathi R, et al. Hypertension. 2016 Feb;67(2):362-7. doi: 10.1161/HYPERTENSIONAHA.115.06300. Epub 2015 Dec 14. Hypertension. 2016. PMID: 26667411 Free PMC article. - Natriuretic peptide system in the human retina.
Rollín R, Mediero A, Roldán-Pallarés M, Fernández-Cruz A, Fernández-Durango R. Rollín R, et al. Mol Vis. 2004 Jan 9;10:15-22. Mol Vis. 2004. PMID: 14737067 - Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. von Haehling S, et al. J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29. J Am Coll Cardiol. 2007. PMID: 17996563 - Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.
Abuzaanona A, Lanfear D. Abuzaanona A, et al. Curr Heart Fail Rep. 2017 Dec;14(6):536-542. doi: 10.1007/s11897-017-0365-5. Curr Heart Fail Rep. 2017. PMID: 29075957 Free PMC article. Review.
Cited by
- Genetic variation in the natriuretic peptide system and heart failure.
Lanfear DE. Lanfear DE. Heart Fail Rev. 2010 May;15(3):219-28. doi: 10.1007/s10741-008-9113-y. Epub 2008 Oct 11. Heart Fail Rev. 2010. PMID: 18850266 Free PMC article. Review. - The plasma B-type natriuretic peptide levels are low in males with stable ischemic heart disease (IHD) compared to those observed in patients with non-IHD: a retrospective study.
Minai K, Ogawa T, Kawai M, Komukai K, Tanaka T, Ogawa K, Nagoshi T, Arase S, Morimoto S, Inoue Y, Sekiyama H, Urabe A, Matsuo S, Hongo K, Yoshimura M. Minai K, et al. PLoS One. 2014 Oct 31;9(10):e108983. doi: 10.1371/journal.pone.0108983. eCollection 2014. PLoS One. 2014. PMID: 25360594 Free PMC article. - Potential association between frequent nonsynonymous variant of NPPA and cardioembolic stroke.
Kim JH, Jang BH, Go HY, Park S, Shin YC, Kim SH, Ko SG. Kim JH, et al. DNA Cell Biol. 2012 Jun;31(6):993-1000. doi: 10.1089/dna.2011.1463. Epub 2012 Mar 8. DNA Cell Biol. 2012. PMID: 22400494 Free PMC article. - Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.
Wu Z, Xu M, Sheng H, Lou Y, Su X, Chen Y, Lu L, Liu Y, Jin W. Wu Z, et al. Int J Clin Exp Pathol. 2014 Sep 15;7(10):7148-57. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25400811 Free PMC article. - Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.
Fox AA, Collard CD, Shernan SK, Seidman CE, Seidman JG, Liu KY, Muehlschlegel JD, Perry TE, Aranki SF, Lange C, Herman DS, Meitinger T, Lichtner P, Body SC. Fox AA, et al. Anesthesiology. 2009 Apr;110(4):738-47. doi: 10.1097/aln.0b013e31819c7496. Anesthesiology. 2009. PMID: 19326473 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous